메뉴 건너뛰기




Volumn 13, Issue 1, 2015, Pages 202-221

Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012

Author keywords

Bioactivity; Marine natural products; Novel compounds; Quantitative analysis

Indexed keywords

ACETAL; ALKALOID; ETHER; LACTONE; NATURAL PRODUCT; PEPTIDE; PHENOL; QUINONE DERIVATIVE; STEROID; TERPENE; BIOLOGICAL PRODUCT;

EID: 84921466639     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13010202     Document Type: Review
Times cited : (207)

References (119)
  • 1
    • 84858308226 scopus 로고    scopus 로고
    • Natural products as sources of new drugs over the 30 years from 1981 to 2010
    • Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311-335.
    • (2012) J. Nat. Prod. , vol.75 , pp. 311-335
    • Newman, D.J.1    Cragg, G.M.2
  • 3
    • 0034082239 scopus 로고    scopus 로고
    • The influence of natural products upon drug discovery
    • Newman, D.J.; Cragg, G.M.; Snader, K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000, 17, 215-234.
    • (2000) Nat. Prod. Rep. , vol.17 , pp. 215-234
    • Newman, D.J.1    Cragg, G.M.2    Snader, K.M.3
  • 4
    • 3042617137 scopus 로고    scopus 로고
    • Advanced preclinical and clinical trials of natural products and related compounds from marine sources
    • Newman, D.J.; Cragg, G.M. Advanced preclinical and clinical trials of natural products and related compounds from marine sources. Curr. Med. Chem. 2004, 11, 1693-1713.
    • (2004) Curr. Med. Chem. , vol.11 , pp. 1693-1713
    • Newman, D.J.1    Cragg, G.M.2
  • 7
    • 0038461995 scopus 로고    scopus 로고
    • Drugs from the deep: Marine natural products as drug candidates
    • Haefner, B. Drugs from the deep: Marine natural products as drug candidates. Drug Discov. Today 2003, 8, 536-544.
    • (2003) Drug Discov. Today , vol.8 , pp. 536-544
    • Haefner, B.1
  • 8
    • 84856406381 scopus 로고    scopus 로고
    • Lessons from the past and charting the future of marine natural products drug discovery and chemical biology
    • Gerwick, W.H.; Moore, B.S. Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chem. Biol. 2012, 19, 85-98.
    • (2012) Chem. Biol. , vol.19 , pp. 85-98
    • Gerwick, W.H.1    Moore, B.S.2
  • 9
    • 77952189751 scopus 로고    scopus 로고
    • Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders
    • Villa, F.A.; Gerwick, L. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders. Immunopharmacol. Immunotoxicol. 2010, 32, 228-237.
    • (2010) Immunopharmacol. Immunotoxicol. , vol.32 , pp. 228-237
    • Villa, F.A.1    Gerwick, L.2
  • 10
    • 0034142130 scopus 로고    scopus 로고
    • Highlights of marine natural products chemistry (1972-1999)
    • Faulkner, D.J. Highlights of marine natural products chemistry (1972-1999). Nat. Prod. Rep. 2000, 17, 1-6.
    • (2000) Nat. Prod. Rep. , vol.17 , pp. 1-6
    • Faulkner, D.J.1
  • 11
    • 67649491097 scopus 로고    scopus 로고
    • A renaissance in marine pharmacology: From preclinical curiosity to clinical reality
    • Glaser, K.B.; Mayer, A.M. A renaissance in marine pharmacology: From preclinical curiosity to clinical reality. Biochem. Pharmacol . 2009, 78, 440-448.
    • (2009) Biochem. Pharmacol , vol.78 , pp. 440-448
    • Glaser, K.B.1    Mayer, A.M.2
  • 13
    • 0035155735 scopus 로고    scopus 로고
    • Marine pharmacology in 1999: Antitumor and cytotoxic compounds
    • Mayer, A.M.; Lehmann, V.K. Marine pharmacology in 1999: Antitumor and cytotoxic compounds. Anticancer Res . 2001, 21, 2489-2500.
    • (2001) Anticancer Res , vol.21 , pp. 2489-2500
    • Mayer, A.M.1    Lehmann, V.K.2
  • 14
    • 0038219974 scopus 로고    scopus 로고
    • Marine pharmacology in 2000: Antitumor and cytotoxic compounds
    • Mayer, A.M.; Gustafson, K.R. Marine pharmacology in 2000: Antitumor and cytotoxic compounds. Int. J. Cancer 2003, 105, 291-299.
    • (2003) Int. J. Cancer , vol.105 , pp. 291-299
    • Mayer, A.M.1    Gustafson, K.R.2
  • 15
    • 9644278102 scopus 로고    scopus 로고
    • Marine pharmacology in 2001-2: Antitumour and cytotoxic compounds
    • Mayer, A.M.; Gustafson, K.R. Marine pharmacology in 2001-2: Antitumour and cytotoxic compounds. Eur. J. Cancer 2004, 40, 2676-2704.
    • (2004) Eur. J. Cancer , vol.40 , pp. 2676-2704
    • Mayer, A.M.1    Gustafson, K.R.2
  • 16
    • 33748125863 scopus 로고    scopus 로고
    • Marine pharmacology in 2003-2004: Anti-tumour and cytotoxic compounds
    • Mayer, A.M.; Gustafson, K.R. Marine pharmacology in 2003-2004: Anti-tumour and cytotoxic compounds. Eur. J. Cancer 2006, 42, 2241-2270.
    • (2006) Eur. J. Cancer , vol.42 , pp. 2241-2270
    • Mayer, A.M.1    Gustafson, K.R.2
  • 17
    • 54249139074 scopus 로고    scopus 로고
    • Marine pharmacology in 2005-2006: Antitumour and cytotoxic compounds
    • Mayer, A.M.; Gustafson, K.R. Marine pharmacology in 2005-2006: Antitumour and cytotoxic compounds. Eur. J. Cancer 2008, 44, 2357-2387.
    • (2008) Eur. J. Cancer , vol.44 , pp. 2357-2387
    • Mayer, A.M.1    Gustafson, K.R.2
  • 18
    • 78249286198 scopus 로고    scopus 로고
    • Antibacterials from the sea
    • Hughes, C.C.; Fenical, W. Antibacterials from the sea. Chemistry 2010, 16, 12512-12525.
    • (2010) Chemistry , vol.16 , pp. 12512-12525
    • Hughes, C.C.1    Fenical, W.2
  • 19
    • 0037865214 scopus 로고    scopus 로고
    • Marine natural products and their potential applications as anti-infective agents
    • Donia, M.; Hamann, M.T. Marine natural products and their potential applications as anti-infective agents. Lancet Infect. Dis. 2003, 3, 338-348.
    • (2003) Lancet Infect. Dis. , vol.3 , pp. 338-348
    • Donia, M.1    Hamann, M.T.2
  • 21
    • 0036024405 scopus 로고    scopus 로고
    • Marine pharmacology in 1999: Compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action
    • Mayer, A.M.; Hamann, M.T. Marine pharmacology in 1999: Compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2002, 132, 315-339.
    • (2002) Comp. Biochem. Physiol. C Toxicol.Pharmacol. , vol.132 , pp. 315-339
    • Mayer, A.M.1    Hamann, M.T.2
  • 22
    • 1642280223 scopus 로고    scopus 로고
    • Marine pharmacology in 2000: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action
    • Mayer, A.M.; Hamann, M.T. Marine pharmacology in 2000: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Mar. Biotechnol. 2004, 6, 37-52.
    • (2004) Mar. Biotechnol. , vol.6 , pp. 37-52
    • Mayer, A.M.1    Hamann, M.T.2
  • 23
    • 20444403434 scopus 로고    scopus 로고
    • Marine pharmacology in 2001-2002: Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action
    • Mayer, A.M.; Hamann, M.T. Marine pharmacology in 2001-2002: Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2005, 140, 265-286.
    • (2005) Comp. Biochem. Physiol. C Toxicol.Pharmacol. , vol.140 , pp. 265-286
    • Mayer, A.M.1    Hamann, M.T.2
  • 24
    • 34247550727 scopus 로고    scopus 로고
    • Marine pharmacology in 2003-4: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action
    • Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2003-4: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol . 2007, 145, 553-581.
    • (2007) Comp. Biochem. Physiol. C Toxicol.Pharmacol. , vol.145 , pp. 553-581
    • Mayer, A.M.1    Rodriguez, A.D.2    Berlinck, R.G.3    Hamann, M.T.4
  • 25
    • 67349092463 scopus 로고
    • Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action
    • Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochim. Biophys. Acta 2009, 1790, 283-308.
    • (1790) Biochim. Biophys. Acta 2009 , pp. 283-308
    • Mayer, A.M.1    Rodriguez, A.D.2    Berlinck, R.G.3    Hamann, M.T.4
  • 26
    • 78650619951 scopus 로고    scopus 로고
    • Marine pharmacology in 2007-2008: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action
    • Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Fusetani, N. Marine pharmacology in 2007-2008: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol . 2011, 153, 191-222.
    • (2011) Comp. Biochem. Physiol. C Toxicol.Pharmacol. , vol.153 , pp. 191-222
    • Mayer, A.M.1    Rodriguez, A.D.2    Berlinck, R.G.3    Fusetani, N.4
  • 27
    • 84880913306 scopus 로고    scopus 로고
    • Marine pharmacology in 2009-2011: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action
    • Mayer, A.M.; Rodriguez, A.D.; Taglialatela-Scafati, O.; Fusetani, N. Marine pharmacology in 2009-2011: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar Drugs 2013, 11, 2510-2573.
    • (2013) Mar Drugs , vol.11 , pp. 2510-2573
    • Mayer, A.M.1    Rodriguez, A.D.2    Taglialatela-Scafati, O.3    Fusetani, N.4
  • 28
    • 37049101409 scopus 로고
    • Marine natural products: Metabolites of marine invertebrates
    • Faulkner, D.J. Marine natural products: Metabolites of marine invertebrates. Nat. Prod. Rep . 1984, 1, 551-598.
    • (1984) Nat. Prod. Rep , vol.1 , pp. 551-598
    • Faulkner, D.J.1
  • 29
    • 37049105062 scopus 로고
    • Marine natural products: Metabolites of marine algae and herbivorous marine molluscs
    • Faulkner, D.J. Marine natural products: Metabolites of marine algae and herbivorous marine molluscs. Nat. Prod. Rep. 1984, 1, 251-280.
    • (1984) Nat. Prod. Rep. , vol.1 , pp. 251-280
    • Faulkner, D.J.1
  • 30
    • 0022666474 scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1986, 3, 1-33.
    • (1986) Nat. Prod. Rep. , vol.3 , pp. 1-33
    • Faulkner, D.J.1
  • 31
    • 0023430057 scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1987, 4, 539-576.
    • (1987) Nat. Prod. Rep. , vol.4 , pp. 539-576
    • Faulkner, D.J.1
  • 32
    • 0024205115 scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1988, 5, 613-663.
    • (1988) Nat. Prod. Rep. , vol.5 , pp. 613-663
    • Faulkner, D.J.1
  • 33
    • 0025475193 scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1990, 7, 269-309.
    • (1990) Nat. Prod. Rep. , vol.7 , pp. 269-309
    • Faulkner, D.J.1
  • 34
    • 0026149047 scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1991, 8, 97-147.
    • (1991) Nat. Prod. Rep. , vol.8 , pp. 97-147
    • Faulkner, D.J.1
  • 35
    • 0000372491 scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1992, 9, 323-364.
    • (1992) Nat. Prod. Rep. , vol.9 , pp. 323-364
    • Faulkner, D.J.1
  • 36
    • 0027672335 scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1993, 10, 497-539.
    • (1993) Nat. Prod. Rep. , vol.10 , pp. 497-539
    • Faulkner, D.J.1
  • 37
    • 0028093929 scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1994, 11, 355-394.
    • (1994) Nat. Prod. Rep. , vol.11 , pp. 355-394
    • Faulkner, D.J.1
  • 38
    • 0029107374 scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1995, 12, 223-269.
    • (1995) Nat. Prod. Rep. , vol.12 , pp. 223-269
    • Faulkner, D.J.1
  • 39
    • 0030131103 scopus 로고    scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1996, 13, 75-125.
    • (1996) Nat. Prod. Rep. , vol.13 , pp. 75-125
    • Faulkner, D.J.1
  • 40
    • 0030841236 scopus 로고    scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1997, 14, 259-302.
    • (1997) Nat. Prod. Rep. , vol.14 , pp. 259-302
    • Faulkner, D.J.1
  • 41
    • 0032054664 scopus 로고    scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1998, 15, 113-158.
    • (1998) Nat. Prod. Rep. , vol.15 , pp. 113-158
    • Faulkner, D.J.1
  • 42
    • 0033118848 scopus 로고    scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1999, 16, 155-198.
    • (1999) Nat. Prod. Rep. , vol.16 , pp. 155-198
    • Faulkner, D.J.1
  • 43
    • 0034141601 scopus 로고    scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 2000, 17, 7-55.
    • (2000) Nat. Prod. Rep. , vol.17 , pp. 7-55
    • Faulkner, D.J.1
  • 44
    • 0035137292 scopus 로고    scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 2001, 18, 1-49.
    • (2001) Nat. Prod. Rep. , vol.18 , pp. 1-49
    • Faulkner, D.J.1
  • 45
    • 0036007872 scopus 로고    scopus 로고
    • Marine natural products
    • Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 2002, 19, 1-48.
    • (2002) Nat. Prod. Rep. , vol.19 , pp. 1-48
    • Faulkner, D.J.1
  • 58
    • 79955598041 scopus 로고    scopus 로고
    • Statistical research on marine natural products based on data obtained between 1985 and 2008
    • Hu, G.P.; Yuan, J.; Sun, L.; She, Z.G.; Wu, J.H.; Lan, X.J.; Zhu, X.; Lin, Y.C.; Chen, S.P. Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar. Drugs 2011, 9, 514-525.
    • (2011) Mar. Drugs , vol.9 , pp. 514-525
    • Hu, G.P.1    Yuan, J.2    Sun, L.3    She, Z.G.4    Wu, J.H.5    Lan, X.J.6    Zhu, X.7    Lin, Y.C.8    Chen, S.P.9
  • 59
    • 56349130803 scopus 로고    scopus 로고
    • Methods for isolation, purification and structural elucidation of bioactive secondary metabolites from marine invertebrates
    • Ebada, S.S.; Edrada, R.A.; Lin, W.; Proksch, P. Methods for isolation, purification and structural elucidation of bioactive secondary metabolites from marine invertebrates. Nat. Protoc . 2008, 3, 1820-1831.
    • (2008) Nat. Protoc , vol.3 , pp. 1820-1831
    • Ebada, S.S.1    Edrada, R.A.2    Lin, W.3    Proksch, P.4
  • 60
    • 34347221246 scopus 로고    scopus 로고
    • Monoindole alkaloids from a marine sponge Spongosorites sp
    • Bao, B.; Zhang, P.; Lee, Y.; Hong, J.; Lee, C.O.; Jung, J.H. Monoindole alkaloids from a marine sponge Spongosorites sp. Mar. Drugs 2007, 5, 31-39.
    • (2007) Mar. Drugs , vol.5 , pp. 31-39
    • Bao, B.1    Zhang, P.2    Lee, Y.3    Hong, J.4    Lee, C.O.5    Jung, J.H.6
  • 61
    • 84884678415 scopus 로고    scopus 로고
    • PTP1B inhibitory secondary metabolites from marine-derived fungal strains Penicillium spp. And Eurotium sp
    • Sohn, J.H.; Lee, Y.R.; Lee, D.S.; Kim, Y.C.; Oh, H. PTP1B inhibitory secondary metabolites from marine-derived fungal strains Penicillium spp. and Eurotium sp. J. Microbiol. Biotechnol. 2013, 23, 1206-1211.
    • (2013) J. Microbiol. Biotechnol. , vol.23 , pp. 1206-1211
    • Sohn, J.H.1    Lee, Y.R.2    Lee, D.S.3    Kim, Y.C.4    Oh, H.5
  • 63
    • 0037116626 scopus 로고    scopus 로고
    • Evolution of anticancer drug discovery and the role of cell-based screening
    • Balis, F.M. Evolution of anticancer drug discovery and the role of cell-based screening. J. Natl. Cancer Inst. 2002, 94, 78-79.
    • (2002) J. Natl. Cancer Inst. , vol.94 , pp. 78-79
    • Balis, F.M.1
  • 66
    • 42949136443 scopus 로고    scopus 로고
    • Genome mining for novel natural product discovery
    • Challis, G.L. Genome mining for novel natural product discovery. J. Med. Chem. 2008, 51, 2618-2628.
    • (2008) J. Med. Chem. , vol.51 , pp. 2618-2628
    • Challis, G.L.1
  • 67
    • 0030770363 scopus 로고    scopus 로고
    • The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB
    • Breton, J.J.; Chabot-Fletcher, M.C. The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB. J. Pharmacol. Exp. Ther. 1997, 282, 459-466.
    • (1997) J. Pharmacol. Exp. Ther. , vol.282 , pp. 459-466
    • Breton, J.J.1    Chabot-Fletcher, M.C.2
  • 68
    • 0030612279 scopus 로고    scopus 로고
    • Inhibition of NFkappaB-mediated interleukin-1beta-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine
    • Roshak, A.; Jackson, J.R.; Chabot-Fletcher, M.; Marshall, L.A. Inhibition of NFkappaB-mediated interleukin-1beta-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine. J. Pharmacol. Exp. Ther. 1997, 283, 955-961.
    • (1997) J. Pharmacol. Exp. Ther. , vol.283 , pp. 955-961
    • Roshak, A.1    Jackson, J.R.2    Chabot-Fletcher, M.3    Marshall, L.A.4
  • 71
    • 70249101414 scopus 로고    scopus 로고
    • Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: Results of a randomized phase II study of two different schedules
    • Demetri, G.D.; Chawla, S.P.; von Mehren, M.; Ritch, P.; Baker, L.H.; Blay, J.Y.; Hande, K.R.; Keohan, M.L.; Samuels, B.L.; Schuetze, S.; et al. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: Results of a randomized phase II study of two different schedules. J. Clin. Oncol. 2009, 27, 4188-4196.
    • (2009) J. Clin. Oncol. , vol.27 , pp. 4188-4196
    • Demetri, G.D.1    Chawla, S.P.2    Von Mehren, M.3    Ritch, P.4    Baker, L.H.5    Blay, J.Y.6    Hande, K.R.7    Keohan, M.L.8    Samuels, B.L.9    Schuetze, S.10
  • 72
    • 77955505177 scopus 로고    scopus 로고
    • A review of trabectedin (ET-743): A unique mechanism of action
    • D'Incalci, M.; Galmarini, C.M. A review of trabectedin (ET-743): A unique mechanism of action. Mol. Cancer Ther. 2010, 9, 2157-2163.
    • (2010) Mol. Cancer Ther. , vol.9 , pp. 2157-2163
    • D'Incalci, M.1    Galmarini, C.M.2
  • 73
    • 77952921894 scopus 로고    scopus 로고
    • Wide-spectrum characterization of trabectedin: Biology, clinical activity and future perspectives
    • Vincenzi, B.; Napolitano, A.; Frezza, A.M.; Schiavon, G.; Santini, D.; Tonini, G. Wide-spectrum characterization of trabectedin: Biology, clinical activity and future perspectives. Pharmacogenomics 2010, 11, 865-878.
    • (2010) Pharmacogenomics , vol.11 , pp. 865-878
    • Vincenzi, B.1    Napolitano, A.2    Frezza, A.M.3    Schiavon, G.4    Santini, D.5    Tonini, G.6
  • 75
    • 84877297872 scopus 로고    scopus 로고
    • 13 years of trabectedin, 5 years of Yondelis(R): What have we learnt?
    • Le Cesne, A. 13 years of trabectedin, 5 years of Yondelis(R): What have we learnt? Expert Rev. Anticancer Ther. 2013, 13, 11-19.
    • (2013) Expert Rev. Anticancer Ther. , vol.13 , pp. 11-19
    • Le Cesne, A.1
  • 78
    • 84879193645 scopus 로고    scopus 로고
    • Natural peptides with potential applications in drug development, diagnosis, and/or biotechnology
    • 2012
    • Hayashi, M.A.; Ducancel, F.; Konno, K. Natural peptides with potential applications in drug development, diagnosis, and/or biotechnology. Int. J. Pept. 2012, 2012, doi:10.1155/2012/757838.
    • (2012) Int. J. Pept.
    • Hayashi, M.A.1    Ducancel, F.2    Konno, K.3
  • 79
    • 84883256420 scopus 로고    scopus 로고
    • Future directions for peptide therapeutics development
    • Kaspar, A.A.; Reichert, J.M. Future directions for peptide therapeutics development. Drug Discov. Today 2013, 18, 807-817.
    • (2013) Drug Discov. Today , vol.18 , pp. 807-817
    • Kaspar, A.A.1    Reichert, J.M.2
  • 80
    • 0033810234 scopus 로고    scopus 로고
    • An evaluation of intrathecal ziconotide for the treatment of chronic pain
    • Jain, K.K. An evaluation of intrathecal ziconotide for the treatment of chronic pain. Expert Opin. Investig. Drugs 2000, 9, 2403-2410.
    • (2000) Expert Opin. Investig. Drugs , vol.9 , pp. 2403-2410
    • Jain, K.K.1
  • 82
    • 17544377633 scopus 로고    scopus 로고
    • Matemone, a new bioactive bromine-containing oxindole alkaloid from the indian ocean sponge Iotrochota purpurea
    • Carletti, I.; Banaigs, B.; Amade, P. Matemone, a new bioactive bromine-containing oxindole alkaloid from the indian ocean sponge Iotrochota purpurea. J. Nat. Prod. 2000, 63, 981-983.
    • (2000) J. Nat. Prod. , vol.63 , pp. 981-983
    • Carletti, I.1    Banaigs, B.2    Amade, P.3
  • 83
    • 0033758451 scopus 로고    scopus 로고
    • Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula
    • Milligan, K.E.; Marquez, B.L.; Williamson, R.T.; Gerwick, W.H. Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2000, 63, 1440-1443.
    • (2000) J. Nat. Prod. , vol.63 , pp. 1440-1443
    • Milligan, K.E.1    Marquez, B.L.2    Williamson, R.T.3    Gerwick, W.H.4
  • 84
    • 0033765654 scopus 로고    scopus 로고
    • Isolation and structure of the cytotoxin lyngbyabellin B and absolute configuration of lyngbyapeptin A from the marine cyanobacterium Lyngbya majuscula
    • Luesch, H.; Yoshida, W.Y.; Moore, R.E.; Paul, V.J. Isolation and structure of the cytotoxin lyngbyabellin B and absolute configuration of lyngbyapeptin A from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2000, 63, 1437-1439.
    • (2000) J. Nat. Prod. , vol.63 , pp. 1437-1439
    • Luesch, H.1    Yoshida, W.Y.2    Moore, R.E.3    Paul, V.J.4
  • 85
    • 0016476488 scopus 로고
    • Impact of the national cancer act on grant support
    • Kalberer, J.T., Jr. Impact of the national cancer act on grant support. Cancer Res . 1975, 35, 472-481.
    • (1975) Cancer Res , vol.35 , pp. 472-481
    • Kalberer, J.T.1
  • 87
    • 9444249285 scopus 로고    scopus 로고
    • National cooperative drug discovery groups (NCDDGs): A successful model for public private partnerships in cancer drug discovery
    • Hallock, Y.F.; Cragg, G.M. National cooperative drug discovery groups (NCDDGs): A successful model for public private partnerships in cancer drug discovery. Pharm. Biol. 2003, 41, 78-91.
    • (2003) Pharm. Biol. , vol.41 , pp. 78-91
    • Hallock, Y.F.1    Cragg, G.M.2
  • 88
    • 70450227226 scopus 로고    scopus 로고
    • The roche research institute of marine pharmacology, 1974-1981: Searching for drug Leads from Australian Marine Organisms
    • Rae, I.D. The roche research institute of marine pharmacology, 1974-1981: Searching for drug Leads from Australian Marine Organisms. Hist. Rec. Aust. Sci. 2009, 20, 209-231.
    • (2009) Hist. Rec. Aust. Sci. , vol.20 , pp. 209-231
    • Rae, I.D.1
  • 89
    • 0003155576 scopus 로고    scopus 로고
    • The NCI In vitro anticancer drug discovery screen
    • 1st ed.; Teicher, B. Humana Press: Totowa, NJ, USA
    • st ed.; Teicher, B., Ed.; Humana Press: Totowa, NJ, USA, 1997; pp. 23-42.
    • (1997) Anticancer Drug Development Guide , pp. 23-42
    • Boyd, M.1
  • 90
    • 0018944539 scopus 로고
    • Drugs from marine organisms: The target of the Roche Research Institute of Marine Pharmacology in Australia
    • Von Berlepsch, K. Drugs from marine organisms: The target of the Roche Research Institute of Marine Pharmacology in Australia. Naturwissenschaften 1980, 67, 338-342.
    • (1980) Naturwissenschaften , vol.67 , pp. 338-342
    • Von Berlepsch, K.1
  • 91
    • 33749011163 scopus 로고    scopus 로고
    • The NCI60 human tumour cell line anticancer drug screen
    • Shoemaker, R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 2006, 6, 813-823.
    • (2006) Nat. Rev. Cancer , vol.6 , pp. 813-823
    • Shoemaker, R.H.1
  • 92
    • 0021061819 scopus 로고
    • Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
    • Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
    • (1983) J. Immunol. Methods , vol.65 , pp. 55-63
    • Mosmann, T.1
  • 93
    • 0023792919 scopus 로고
    • Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
    • Scudiero, D.A.; Shoemaker, R.H.; Paull, K.D.; Monks, A.; Tierney, S.; Nofziger, T.H.; Currens, M.J.; Seniff, D.; Boyd, M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48, 4827-4833.
    • (1988) Cancer Res. , vol.48 , pp. 4827-4833
    • Scudiero, D.A.1    Shoemaker, R.H.2    Paull, K.D.3    Monks, A.4    Tierney, S.5    Nofziger, T.H.6    Currens, M.J.7    Seniff, D.8    Boyd, M.R.9
  • 96
    • 0033945101 scopus 로고    scopus 로고
    • Antineoplastic agents 430. Isolation and structure of cribrostatins 3, 4, and 5 from the republic of maldives cribrochalina species
    • Pettit, G.R.; Knight, J.C.; Collins, J.C.; Herald, D.L.; Pettit, R.K.; Boyd, M.R.; Young, V.G. Antineoplastic agents 430. Isolation and structure of cribrostatins 3, 4, and 5 from the republic of maldives cribrochalina species. J. Nat. Prod. 2000, 63, 793-798.
    • (2000) J. Nat. Prod. , vol.63 , pp. 793-798
    • Pettit, G.R.1    Knight, J.C.2    Collins, J.C.3    Herald, D.L.4    Pettit, R.K.5    Boyd, M.R.6    Young, V.G.7
  • 97
    • 0034865734 scopus 로고    scopus 로고
    • New bromoditerpenes from the red alga Sphaerococcus coronopifolius
    • Etahiri, S.; Bultel-Ponce, V.; Caux, C.; Guyot, M. New bromoditerpenes from the red alga Sphaerococcus coronopifolius. J. Nat. Prod. 2001, 64, 1024-1027.
    • (2001) J. Nat. Prod. , vol.64 , pp. 1024-1027
    • Etahiri, S.1    Bultel-Ponce, V.2    Caux, C.3    Guyot, M.4
  • 98
    • 0035200190 scopus 로고    scopus 로고
    • Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge
    • Cueto, M.; Jensen, P.R.; Kauffman, C.; Fenical, W.; Lobkovsky, E.; Clardy, J. Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge. J. Nat. Prod. 2001, 64, 1444-1446.
    • (2001) J. Nat. Prod. , vol.64 , pp. 1444-1446
    • Cueto, M.1    Jensen, P.R.2    Kauffman, C.3    Fenical, W.4    Lobkovsky, E.5    Clardy, J.6
  • 99
    • 84905919391 scopus 로고    scopus 로고
    • Confronting the challenges of discovery of novel antibacterial agents
    • Singh, S.B. Confronting the challenges of discovery of novel antibacterial agents. Bioorg. Med. Chem. Lett . 2014, 24, 3683-3689.
    • (2014) Bioorg. Med. Chem. Lett , vol.24 , pp. 3683-3689
    • Singh, S.B.1
  • 100
    • 78751477224 scopus 로고    scopus 로고
    • Challenges of antibacterial discovery
    • Silver, L.L. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 2011, 24, 71-109.
    • (2011) Clin. Microbiol. Rev. , vol.24 , pp. 71-109
    • Silver, L.L.1
  • 101
    • 0034727834 scopus 로고    scopus 로고
    • Managing antibiotic resistance
    • Wenzel, R.P.; Edmond, M.B. Managing antibiotic resistance. N. Engl. J. Med. 2000, 343, 1961-1963.
    • (2000) N. Engl. J. Med. , vol.343 , pp. 1961-1963
    • Wenzel, R.P.1    Edmond, M.B.2
  • 103
  • 104
    • 15544384259 scopus 로고    scopus 로고
    • Antibacterial drug discovery: Is it all downhill from here?
    • Projan, S.J.; Shlaes, D.M. Antibacterial drug discovery: Is it all downhill from here? Clin. Microbiol. Infect. 2004, 10, 18-22.
    • (2004) Clin. Microbiol. Infect. , vol.10 , pp. 18-22
    • Projan, S.J.1    Shlaes, D.M.2
  • 105
    • 0242291985 scopus 로고    scopus 로고
    • Why is big Pharma getting out of antibacterial drug discovery?
    • Projan, S.J. Why is big Pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 2003, 6, 427-430.
    • (2003) Curr. Opin. Microbiol. , vol.6 , pp. 427-430
    • Projan, S.J.1
  • 106
    • 69549111337 scopus 로고    scopus 로고
    • Antibiotics for emerging pathogens
    • Fischbach, M.A.; Walsh, C.T. Antibiotics for emerging pathogens. Science 2009, 325, 1089-1093.
    • (2009) Science , vol.325 , pp. 1089-1093
    • Fischbach, M.A.1    Walsh, C.T.2
  • 107
    • 84886542459 scopus 로고    scopus 로고
    • Drug discovery for neglected diseases: Molecular target-based and phenotypic approaches
    • Gilbert, I.H. Drug discovery for neglected diseases: Molecular target-based and phenotypic approaches. J. Med. Chem. 2013, 56, 7719-7726.
    • (2013) J. Med. Chem. , vol.56 , pp. 7719-7726
    • Gilbert, I.H.1
  • 108
    • 0038155163 scopus 로고    scopus 로고
    • Biofilm-specific cross-species induction of antimicrobial compounds in bacilli
    • Yan, L.M.; Boyd, K.G.; Adams, D.R.; Burgess, J.G. Biofilm-specific cross-species induction of antimicrobial compounds in bacilli. Appl. Environ. Microbiol. 2003, 69, 3719-3727.
    • (2003) Appl. Environ. Microbiol. , vol.69 , pp. 3719-3727
    • Yan, L.M.1    Boyd, K.G.2    Adams, D.R.3    Burgess, J.G.4
  • 109
    • 79954431143 scopus 로고    scopus 로고
    • Cross-species induction of antimicrobial compounds, biosurfactants and quorum-sensing inhibitors in tropical marine epibiotic bacteria by pathogens and biofouling microorganisms
    • Dusane, D.H.; Matkar, P.; Venugopalan, V.P.; Kumar, A.R.; Zinjarde, S.S. Cross-Species Induction of Antimicrobial Compounds, Biosurfactants and Quorum-Sensing Inhibitors in Tropical Marine Epibiotic Bacteria by Pathogens and Biofouling Microorganisms. Curr. Microbiol. 2011, 62, 974-980.
    • (2011) Curr. Microbiol. , vol.62 , pp. 974-980
    • Dusane, D.H.1    Matkar, P.2    Venugopalan, V.P.3    Kumar, A.R.4    Zinjarde, S.S.5
  • 110
    • 79959811774 scopus 로고    scopus 로고
    • Bacterial symbionts and natural products
    • Crawford, J.M.; Clardy, J. Bacterial symbionts and natural products. Chem. Commun. 2011, 47, 7559-7566.
    • (2011) Chem. Commun. , vol.47 , pp. 7559-7566
    • Crawford, J.M.1    Clardy, J.2
  • 112
    • 84893928918 scopus 로고    scopus 로고
    • Diversity, abundance and natural products of marine sponge-associated actinomycetes
    • Abdelmohsen, U.R.; Bayer, K.; Hentschel, U. Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat. Prod. Rep. 2014, 31, 381-399.
    • (2014) Nat. Prod. Rep. , vol.31 , pp. 381-399
    • Abdelmohsen, U.R.1    Bayer, K.2    Hentschel, U.3
  • 113
    • 78049442273 scopus 로고    scopus 로고
    • Immense essence of excellence: Marine microbial bioactive compounds
    • Bhatnagar, I.; Kim, S.K. Immense essence of excellence: Marine microbial bioactive compounds. Mar. Drugs 2010, 8, 2673-2701.
    • (2010) Mar. Drugs , vol.8 , pp. 2673-2701
    • Bhatnagar, I.1    Kim, S.K.2
  • 119
    • 80052498659 scopus 로고    scopus 로고
    • Marine natural products: A new wave of drugs?
    • Montaser, R.; Luesch, H. Marine natural products: A new wave of drugs? Future Med. Chem. 2011, 3, 1475-1489.
    • (2011) Future Med. Chem. , vol.3 , pp. 1475-1489
    • Montaser, R.1    Luesch, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.